Nancy Andrews (biologist)

Source: Wikipedia, the free encyclopedia.
Nancy C. Andrews
Joan Steitz
Stuart Orkin

Nancy C. Andrews (born November 29, 1958) is an American biologist and physician noted for her research on iron homeostasis. Andrews was formerly Dean of the Duke University School of Medicine.[1][2]

Biography

Andrews grew up in

Children's Hospital Boston
.

Andrews then joined the faculty at

endowed chair in 2003, and the position of Dean for Basic Sciences and Graduate Studies at Harvard Medical School. In 2007, Andrews left to take a position as the first female Dean of Medicine at Duke University.[1][3] In this position, she was the only woman heading any of the top ten medical schools in the U.S.[1][4] She stepped down from the Deanship in 2017.[2]
Andrews was selected as the Executive Vice President and Chief Scientific Officer at Boston Children's Hospital in November 2021.

Andrews studied treatments for and molecular processes governing iron disease, such as

Andrews currently serves as Chair of the Board of Directors of the American Academy of Arts and Sciences [6][7] and is a member of the Boards of Directors of Novartis,[8] Charles River Laboratories and Maze Therapeutics.

Personal life

She is married to fellow biologist Bernard Mathey-Prevot. She is the great-granddaughter of

Mary Raymond Shipman Andrews, and great-great-granddaughter of New York Court of Appeals Chief Judge Charles Andrews and Bishop Frederic Dan Huntington.[citation needed] She is also the great-niece of composer Roger Sessions
, who was the brother of her paternal grandmother, Hannah Sargent Sessions Andrews.

Awards and honors

  • 1993–2006, Investigator, Howard Hughes Medical Institute
  • 1998 Samuel Rosenthal Prize for Excellence in Academic Pediatrics
  • 2000 American Federation for Medical Research Foundation Outstanding Investigator Award in Basic Science
  • 2002 E. Mead Johnson Award from the Society for Pediatric Research
  • 2004 Dean's Leadership Award for the Advancement of Women Faculty at Harvard Medical School.
  • 2006 Elected to the
    National Academies of Science
  • 2007 Elected as a Fellow of the American Academy of Arts and Sciences[9]
  • 2010 Vanderbilt Prize in Biomedical Science
  • 2013 Henry M. Stratton Medal, American Society of Hematology
  • 2015 Elected to the National Academy of Sciences

Selected works

  • Andrews NC, Erdjument-Bromage H, Davidson MB, Tempst P, Orkin SH. Erythroid transcription factor NF-E2 is a haematopoietic-specific basic-leucine zipper protein. Nature 1993; 362:722-8.
  • Fleming MD, Trenor CC 3rd, Su MA, Foernzler D, Beier DR, Dietrich WF, and Andrews NC. Microcytic anemia mice have a mutation in Nramp2, a candidate iron transporter gene. Nature Genetics 1997; 16:383-6.
  • Levy JE, Jin O, Fujiwara Y, Kuo F, Andrews NC. Transferrin receptor is necessary for development of erythrocytes and the nervous system. Nature Genetics 1999; 21:396-9.
  • Andrews NC. Medical Progress: Disorders of Iron Metabolism. New England Journal of Medicine 1999;341:1986-95.
  • Donovan A, Brownlie A, Zhou Y, Shepard J, Pratt SJ, Moynihan J, Paw BH, Drejer A, Barut B, Zapata A, Law TC, Brugnara C, Lux SE, Pinkus GS, Pinkus JL, Kingsley PD, Palis J, Fleming MD, Andrews NC, Zon LI. Positional cloning of zebrafish ferroportin 1 identifies a conserved vertebrate iron exporter. Nature 2000; 403:776-81.
  • Andrews NC. The other physician-scientist problem: where have all the young girls gone? Nature Medicine 2002; 8:439-41.
  • Donovan A, Lima CA, Pinkus JL, Pinkus GS, Zon LI, Robine S, Andrews NC. The iron exporter ferroportin (Slc40a1) is essential for iron homeostasis. Cell Metabolism 2005; 1:191-200.
  • Gunshin H, Fujiwara Y, Custodio A, DiRenzo C, Robine S, Andrews NC. Slc11a2 is required for intestinal iron absorption and erythropoiesis but dispensable in placenta and liver. Journal of Clinical Investigation 2005; 115(5):1258-1266.
  • Schmidt PJ, Toran PT, Giannetti AM, Bjorkman PJ and Andrews NC. The transferrin receptor modulates Hfe-dependent regulation of hepcidin expression. Cell Metabolism 2008; 7:205-14.
  • Finberg KE, Heeney MM, Campagna DR, Aydinok Y, Pearson HA, Hartman KR, Mayo MM, Samuel SM, Strouse JJ, Markianos K, Andrews NC, Fleming MD. Mutations in TMPRSS6 cause iron-refractory, iron deficiency anemia. Nature Genetics 2008; 40:569-571.
  • Xu W, Barrientos T, Mao L, Rockman HA, Sauve AA, Andrews NC. Lethal cardiomyopathy in mice lacking transferrin receptor in the heart. Cell Reports 2015; 13:533-45.

References

  1. ^ a b c d e Duke University, "Harvard Physician-Scientist Named Dean of Duke University School of Medicine", August 27, 2007
  2. ^ a b "School of Medicine Dean Dr. Nancy Andrews to Step Down in 2017". today.duke.edu. Retrieved 2019-07-24.
  3. Wall Street Journal
    , Aug. 28, 2007.
  4. ^ "Andrews Makes History at Duke Med School", Interview with Dr. Nancy Andrews, NPR, Sept. 2, 2007 (Andrews discusses "the challenges facing women in medicine and where medical education is headed").
  5. ^ "Iron Exporter Revealed That May Explain Common Human Disorder", ScienceDaily, Mar. 31, 2005.
  6. ^ "Board of Directors". American Academy of Arts & Sciences. Retrieved 2019-07-24.
  7. ^ "Nancy C. Andrews". American Academy of Arts & Sciences. Retrieved 2019-07-24.
  8. ^ "Nancy C. Andrews, M.D., Ph.D." Novartis. Retrieved 2019-07-24.
  9. ^ "Book of Members, 1780-2010: Chapter A" (PDF). American Academy of Arts and Sciences. Retrieved 18 April 2011.

External links